GlassScriptPhysician profile
Pamela Stearns
NPI 1376581801
$5,296.50
in general payments reported to CMS, 2019-2025
40 companies · $671 in 2025
The $671 reported for 2025 was more than what 79% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $419 · 2020: $1,147 · 2021: $1,184 · 2022: $581 · 2023: $896 · 2024: $398 · 2025: $671.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,965.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,964.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,027.96 | 2020-2025 | Jardiance, Synjardy |
| Lilly USA, LLC | $583.93 | 2019-2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $476.43 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amarin Pharma, INC. | $452.70 | 2019-2022 | |
| Glaxosmithkline, LLC. | $344.52 | 2019-2024 | Arexvy, Trelegy Ellipta, Shingrix |
| Amgen INC. | $335.79 | 2019-2023 | Repatha, Prolia, Evenity |
| Astrazeneca Pharmaceuticals LP | $317.14 | 2019-2024 | Airsupra, Farxiga |
| Pfizer INC. | $311.99 | 2021-2025 | |
| Allergan, INC. | $154.06 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $153.91 | 2019-2023 | Austedo |
| Abbvie INC. | $150.14 | 2020-2021 | |
| Exact Sciences Corporation | $112.18 | 2023-2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $106.86 | 2020-2021 | |
| Gilead Sciences, INC. | $95.54 | 2019-2025 | |
| Mayne Pharma Commercial LLC | $90.16 | 2025 |
Show all 39 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pamela Stearns listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.